Related Experiment Video

Updated: Jun 17, 2025

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

6.4K

Nanoparticles crossing blood-brain barrier need specific design for normal, neurodegenerative or cancerous brain

Julia Y Ljubimova1, Eggehard Holler1,2, Keith L Black3,4

  • 1Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA.

Nanomedicine (London, England)
|August 7, 2024
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Alzheimer's and tumorBBBCNS immunityDiabetic retinopathyblood brain barrier (BBB)cell-specific drug deliverycentral nervous systemmultifunctional nanoparticlesnormalpeptides

More Related Videos

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish
13:34

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish

Published on: April 16, 2019

9.1K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.5K

Related Experiment Videos

Last Updated: Jun 17, 2025

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

6.4K
Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish
13:34

Predicting In Vivo Payloads Delivery using a Blood-brain Tumor-barrier in a Dish

Published on: April 16, 2019

9.1K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.5K

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

47.1K
Overview
47.1K
Physiological Barriers01:25

Physiological Barriers

3.5K
Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
3.5K

Articles linked to this work by shared authors, journal, and citation graph.

Synergistic retinal UCHL1 dysregulation and synaptic vulnerability reflect Alzheimer's disease severity.

bioRxiv : the preprint server for biology·2026

Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer's disease retina.

Nature communications·2026

Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer's disease retina.

Research square·2025

Exosomes as Future Therapeutic Tools and Targets for Corneal Diseases.

Cells·2025

Antibody-Free Immunopeptide Nano-Conjugates for Brain-Targeted Drug Delivery in Glioblastoma Multiforme.

bioRxiv : the preprint server for biology·2025

Antigen-specific age-related memory CD8 T cells induce and track Alzheimer's-like neurodegeneration.

Proceedings of the National Academy of Sciences of the United States of America·2024

mRNA-based nanomedicine for diabetic wound repair: advances in LNP delivery, immune modulation, and regenerative pathways.

Nanomedicine (London, England)·2026

Evolving skin cancer therapeutics: molecular and genetic drivers, immunotherapy challenges, and advances in nanogel-based nanomedicine.

Nanomedicine (London, England)·2026

Cardiac nanomedicine for ischemic injury and remodeling: imaging and therapy.

Nanomedicine (London, England)·2026

New approach methodologies to model the female reproductive tract: advances and opportunities for nanomedicine.

Nanomedicine (London, England)·2026

Heat-preconditioned MSC-derived exosomal miR‑486‑5p reverses doxorubicin resistance in breast cancer.

Nanomedicine (London, England)·2026

Dendrimer 'protein corona': mechanism of interaction, characterization, and implications in drug delivery.

Nanomedicine (London, England)·2026

Neuroprotective Effect of Imeglimin Hydrochloride on H2O2-Induced SH-SY5Y Cells.

Central nervous system agents in medicinal chemistry·2026

Associations of serum BDNF and Val66Met (rs6265) BDNF gene polymorphism with depressive symptoms and cognitive performance after ischemic stroke: a prospective cohort study.

Neurologia i neurochirurgia polska·2026

Diagnostic classifications based on cognitive, CSF, and PET biomarkers across ADNI cohorts: cross-sectional and longitudinal variability.

Brain communications·2026

Depressive and anxiety symptom trajectories in psychiatric inpatients with nosocomial infection: a retrospective study from China.

Frontiers in psychiatry·2026

Effects and safety of repetitive transcranial magnetic stimulation on cognitive outcomes in mild cognitive impairment: a systematic review and meta-analysis.

Frontiers in aging neuroscience·2026

Association of the systemic immune-inflammation index with consciousness disturbance in cerebral venous sinus thrombosis: a retrospective cohort study.

Frontiers in immunology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us